EUVIMEDEUVIMED entdecken
Crossref

Monocentric Study on the Performance of Noninvasive Prenatal Testing on Cell‐Free DNA for the Detection of Monosomy X

Kelly Steinfort, Erik Fransen, Bettina Blaumeiser iD, Katrien Janssens iD

Prenatal Diagnosis · 2024

DOI: 10.1002/pd.6643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, 2024. Verfasst von Kelly Steinfort und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Antwerp University Hospital, UZA, ASTARC Antwerp University, Antwerp, Belgium. Hauptthemen laut MEDLINE: Noninvasive Prenatal Testing, Turner Syndrome, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Increasing the PPV of monosomy X detected by the non‐invasive prenatal test (NIPT) by discriminating a (mosaic) monosomy X genotype of fetal versus maternal origin.

Methods

Out of 30,700 women referred for NIPT between January 2014 and December 2021, 79 had a high risk result for 45,X. Discrimination between fetal and maternal 45,X was made based on the values for ffX, ffY and SeqFF. Follow‐up was provided through analysis of amniotic fluid, maternal blood, umbilical cord blood, neonatal blood and/or placental biopsies.

Results

Follow‐up data were available for 70/79 women; after exclusion of one twin pregnancy, 69 pregnancies were evaluated (87.3%). Forty one of those were correctly predicted as being maternal or fetal, for an overall PPV of 59.4% (95% confidence interval [CI] 47%–71%). Of the 33 predicted fetal cases with follow‐up, 11 were indeed of fetal origin, equating to a PPV of 33.3% (95% CI 18%–52%); three additional cases turned out to be placental in origin, six were maternal and for 13, no explanation could be found. The PPV of maternal cases was 88.2% (30/34 cases with follow‐up correctly predicted; 95% CI 73%–97%). One case turned out to be fetal; for the other three, follow‐up studies failed to prove the presence of monosomy X. Two cases for which no prediction on the origin of the monosomy X could be made (inconclusive high‐risk NIPT result) turned out to have confined placental mosaicism.

Conclusion

Although the PPV for fetal monosomy X remains lower than for the common trisomies, the total PPV for 45,X screening with NIPT can be improved by discerning fetal from (mosaic) maternal 45,X genotype. Thorough follow‐up to determine the origin of the aberrant NIPT result is advised, so that women can be adequately counseled on the risk in their current and future pregnancies and, in case of maternal mosaic monosomy X, of their own prospects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noninvasive Prenatal TestingTurner SyndromeCell-Free Nucleic AcidsHumansFemalePregnancyAdultMonosomy

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Antwerp University Hospital, UZA, ASTARC Antwerp University, Antwerp, Belgium.
  • Center of Medical Genetics, Antwerp University Hospital, (CMG-UZA) and University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Bettina Blaumeiser, Katrien Janssens

Zitieren

APA

Steinfort, K., Fransen, E., Blaumeiser, B., & Janssens, K. (2024). Monocentric Study on the Performance of Noninvasive Prenatal Testing on Cell‐Free DNA for the Detection of Monosomy X. Prenatal Diagnosis. https://doi.org/10.1002/pd.6643

Vancouver

Steinfort K, Fransen E, Blaumeiser B, Janssens K. Monocentric Study on the Performance of Noninvasive Prenatal Testing on Cell‐Free DNA for the Detection of Monosomy X. Prenatal Diagnosis. 2024. doi:10.1002/pd.6643

BibTeX
@article{Steinfort2024,
  author = {Steinfort, Kelly and Fransen, Erik and Blaumeiser, Bettina and Janssens, Katrien},
  title = {Monocentric Study on the Performance of Noninvasive Prenatal Testing on Cell‐Free DNA for the Detection of Monosomy X},
  journal = {Prenatal Diagnosis},
  year = {2024},
  doi = {10.1002/pd.6643}
}
Kostenlos starten →